Ultrasound in Medicine and Biology
Volume 36, Issue 3 , Pages 441-448 , March 2010

Dendritic Cells Loaded with Ultrasound-Ablated Tumour Induce in vivo Specific Antitumour Immune Responses

  • Jian Deng
    • ,
  • Ying Zhang
    • ,
  • Jun Feng
    • ,
  • Feng Wu

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Dr. Feng Wu, Box 153, Institute of Ultrasonic Engineering in Medicine, Chongqing Medical University, 1 Medical College Road, Chongqing 400016, China.

Received 7 September 2009 ,Revised 4 December 2009 ,Accepted 17 December 2009.

References 

  1. Appleman LJ, Boussiotis VA. T cell energy and co-stimulation. Immunol Rev. 2003;192:161–180
  2. Aranami T, Iwabuchi K, Onoe K. Syngeneic mixed lymphocyte reaction (SMLR) with dendritic cells: Direct visualization of dividing T cell subsets in SMLR. Cell Immunol. 2002;217:67–77
  3. Bounous DI, Campagnoli RP, Brown J. Comparison of MTT colorimetric assay and tritiated thymidine uptake for lymphocyte proliferation assays using chicken splenocytes. Avian Dis. 1992;36:1022–1027
  4. Chaussy C, Thuroff S, Rebillard X, Gelet A. Technology insight: High-intensity focused ultrasound for urologic cancers. Nat Clin Pract Urol. 2005;2:191–198
  5. Fried NM, Roberts WW, Sinelnikov YD, Wright EJ, Solomon SB. Focused ultrasound ablation of the epididymis with use of thermal measurements in a canine model. Fertil Steril. 2002;78:609–613
  6. Gieni RS, Li Y, HayGlass KT. Comparison of [3H]thymidine incorporation with MTT- and MTS-based bioassays for human and murine IL-2 and IL-4 analysis. Tetrazolium assays provide markedly enhanced sensitivity. J Immunol Methods. 1995;187:85–93
  7. Goldszmid RS, Idoyaga J, Bravo AI, Steinman R, Mordoh J, Wainstok R. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8 + T cell immunity against B16 melanoma. J Immunol. 2003;171:5940–5947
  8. Heo DS, Park JG, Hata K, Day R, Herberman RB, Whiteside TL. Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity. Cancer Res. 1990;50:3681–3690
  9. Hong K, Georgiades CS, Geschwind JF. Technology insight: Image-guided therapies for hepatocellular carcinoma—intra-arterial and ablative techniques. Nat Clin Pract Oncol. 2006;3:315–324
  10. Hu Z, Yang XY, Liu Y, Morse MA, Lyerly HK, Clay TM, et al. Release of endogenous danger signals from HIFU-treated tumour cells and their stimulatory effects on APCs. Biochem Biophys Res Commun. 2005;335:124–131
  11. Hu Z, Yang XY, Liu Y, Sankin GN, Pua EC, Morse MA, et al. Investigation of HIFU-induced anti-tumor immunity in a murine tumor model. J Transl Med. 2007;5:34–43
  12. Hundt W, O'Connell-Rodwell CE, Bednarski MD, Steinbach S, Guccione S. In vitro effect of focused ultrasound or thermal stress on HSP70 expression and cell viability in three tumor cell lines. Acad Radiol. 2007;14:859–870
  13. Hussain RF, Nouri AM, Oliver RT. A new approach for measurement of cytotoxicity using colorimetric assay. J Immunol Methods. 1993;160:89–96
  14. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med. 1992;176:1693–1702
  15. Kennedy JE. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer. 2005;5:321–327
  16. Kramer G, Steiner GE, Grobl M, Hrachowitz K, Reithmayr F, Paucz L, et al. Response to sublethal heat treatment of prostatic tumor cells and of prostatic tumor infiltrating T-cells. Prostate. 2004;58:109–120
  17. Li JH, Rosen D, Sondel P, Berke G. Immune privilege and FasL: Two ways to inactivate effector cytotoxic T lymphocytes by FasL-expressing cells. Immunology. 2002;105:267–277
  18. Liapi E, Geschwind JF. Transcatheter and ablative therapeutic approaches for solid malignancies. J Clin Oncol. 2007;25:978–986
  19. Lu P, Zhu XQ, Xu ZL, Zhou Q, Zhang J, Wu F. Increased Infiltration of activated tumor-infiltrating lymphocytes after high-intensity focused ultrasound ablation of human breast cancer. Surgery. 2009;145:286–293
  20. Lutz MB, Schuler G. Immature: Semi-mature and fully mature dendritic cells: Which signals induce tolerance or immunity?. Trends Immunol. 2002;23:445–449
  21. Madersbacher S, Kratzik C, Marberger M. Prostatic tissue ablation by transrectal high intensity focused ultrasound: Histological impact and clinical application. Ultrasonics Sonochem. 1997;4:175–179
  22. Madersbacher S, Grobl M, Kramer G, Dirnhofer S, Steiner GE, Marberger M. Regulation of heat shock protein 27 expression of prostatic cells in response to heat treatment. Prostate. 1998;37:174–181
  23. Melief CJ. Cancer immunotherapy by dendritic cells. Immunity. 2008;29:372–383
  24. Neidhardt-Berard EM, Berard F, Banchereau J, Palucka AK. Dendritic cells loaded with killed breast cancer cells induce differentiation of tumor-specific cytotoxic T lymphocytes. Breast Cancer Res. 2004;6:R322–R328
  25. O'Neill DW, Adams S, Bhardwaj N. Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood. 2004;104:2235–2246
  26. Pockley AG. Heat shock proteins as regulators of the immune response. Lancet. 2003;362:469–476
  27. Prasad SJ, Farrand KJ, Matthews SA, Chang JH, McHugh RS, Ronchese F. Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4+CD25+ regulatory T cells. J Immunol. 2005;174:90–98
  28. Rosberger DF, Coleman DJ, Silverman R, Woods S, Rondeau M, Cunningham-Rundles S. Immunomodulation in choroidal melanoma: Reversal of inverted CD4/CD8 ratios following treatment with ultrasonic hyperthermia. Biotechnol Ther. 1994;5:59–68
  29. Schnurr M, Chen Q, Shin A, Chen W, Toy T, Jenderek C, et al. Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery. Blood. 2005;105:2465–2472
  30. Seong SY, Matzinger P. Hydrophobicity: An ancient damage associated molecular pattern that initiates innate immune responses. Nat Rev Immunol. 2004;4:469–478
  31. Timmerman RD, Bizekis CS, Pass HI, Fong Y, Dupuy DE, Dawson LA, et al. Local surgical, ablative, and radiation treatment of metastases. CA Cancer J Clin. 2009;59:145–170
  32. Vitale M, Pelusi G, Taroni B, Gobbi G, Micheloni C, Rezzani R, et al. HLA class I antigen down-regulation in primary ovary carcinoma lesions: Association with disease stage. Clin Cancer Res. 2005;11:67–72
  33. Wagner U, Burkhardt E, Failing K. Evaluation of canine lymphocyte proliferation: Comparison of three different colorimetric methods with the 3H-thymidine incorporation assay. Vet Immunol Immunopathol. 1999;70:151–159
  34. Wang X, Sun J. High-intensity focused ultrasound in patients with late-stage pancreatic carcinoma. Chin Med J (Engl). 2002;115:1332–1335
  35. Wu F, Chen WZ, Bai J, Zou JZ, Wang ZL, Zhu H, et al. Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Bio. 2001;l27:1099–1106
  36. Wu F, Wang ZB, Lu P, Xu ZL, Chen WZ, Zhu H, et al. Activated anti-tumor immunity in cancer patients after high-intensity focused ultrasound ablation. Ultrasound Med Biol. 2004;30:1217–1222
  37. Wu F. Extracorporeal high-intensity focused ultrasound in the treatment of patients with solid malignancy. Minim Invasive Ther Allied Technol. 2006;15:26–35
  38. Wu F, Wang ZB, Cao YD, Zhou Q, Zhang Y, Xu ZL, et al. Expression of tumour antigens and heat-shock protein 70 in breast cancer cells after high-intensity focused ultrasound ablation. Ann Surg Oncol. 2007;14:1237–1242
  39. Xu ZL, Zhu XQ, Lu P, Zhou Q, Zhang J, Wu F. Activation of tumor-infiltrating antigen presenting cells by high-intensity focused ultrasound ablation of human breast cancer. Ultrasound Med Biol. 2009;35:50–57

PII: S0301-5629(09)01681-0

doi: 10.1016/j.ultrasmedbio.2009.12.004

Ultrasound in Medicine and Biology
Volume 36, Issue 3 , Pages 441-448 , March 2010

Article Tools

* Image Usage & Resolution